Cho, Soohyun
Kim, Byung–Kun
Article History
Accepted: 12 April 2024
First Online: 29 April 2024
Compliance with Ethical Standards
:
: Soohyun Cho received honoraria as a speaker from Celltrion Pharm, Daewoong Pharm, Boryung, Whan In Pharm, Teva and SK Pharm. He has been the principal investigator of clinical trials sponsored by Teva and SK Pharm. Byung–Kun Kim served on Lundbeck’s Advisory Board. He received honoraria as a moderator and speaker from Lundbeck, AbbVie, Pfizer, Eli Lilly, Teva, Yuyu Pharm, and SK Pharm. He has been the principal investigator of clinical trials sponsored by Eli–Lilly, Novartis, Lundbeck, Teva, AbbVie, and Ildong Pharm.
: This article does not contain any studies with human or animal subjects performed by any of the authors.